The winners and losers of Biden’s plans to expand coverage of weight-loss drugs US President Joe Biden wants to expand the ...

President-elect Donald J. Trump’s selections to run the nation’s health agencies are alarming infectious disease experts.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

A new Biden administration proposal could allow millions of Americans with obesity to access weight-loss drugs like Wegovy ...

Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

Last, the administration's proposal also tries to shore up guardrails for the use of AI in health care with edits to existing ...

West Virginia Gov. and Senator-elect Jim Justice said Tuesday he supports a plan by President Joe Biden’s administration to expand access to costly weight-loss drugs like Ozempic and Wegovy, but ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...